...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Patient Preference and Adherence >Interactive Network Platform Improves Compliance and Efficacy of Subcutaneous Immunotherapy for Patients with Allergic Rhinitis
【24h】

Interactive Network Platform Improves Compliance and Efficacy of Subcutaneous Immunotherapy for Patients with Allergic Rhinitis

机译：互动网络平台可提高皮下免疫疗法对过敏性鼻炎患者的合规性和疗效

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: Allergic rhinitis (AR) is a common chronic inflammatory disease of nasal mucosa worldwide, and its symptoms seriously affect the lives of patients. Subcutaneous immunotherapy (SCIT) is an effective treatment for AR, but it is also associated with low patient compliance and difficulties in fully achieving therapeutic effects. Objective: In this prospective randomized controlled study, we verified the effects of an interactive network platform named “U breath” in improving patient compliance and the efficacy of SCIT in patients with AR. Methods: A total of 148 patients who received SCIT were recruited as participants and randomly assigned to either the standardized management (SM) or the interactive network platform management (INP) group. The SM group experienced the standard management SCIT process. The INP group experienced a new management approach based on an interactive network platform called “U breath”. The compliance rate, combined symptom and medication score (CSMS), visual analogue scale score and the rhinoconjunctivitis quality of life questionnaire (RQLQ) results were evaluated at baseline and 1-year postintervention for the two groups. Results: Within the first year of treatment, the INP group had a higher compliance rate than did the SM group, with a statistically significant difference (P0.05). The INP group showed better clinical improvement than the SM group did in terms of the VAS score, and the RQLQ score except the sleep problems (P 0.05). Conclusion: This study confirmed that the application of an interactive network platform is of great significance for improving patient compliance and the treatment effects of SCIT in patients with AR.
机译：背景：过敏性鼻炎（AR）是全球鼻粘膜的常见慢性炎症疾病，其症状严重影响了患者的生命。皮下免疫疗法（SCIT）是对AR的有效处理，但它也与患者依从性和困难有关，完全达到治疗效果。目的：在这项前瞻性随机对照研究中，我们验证了名为“U呼吸”的互动网络平台在提高患者依从性和患者患者患者患者的疗效的影响。方法：招募了148名接受SCIT的患者作为参与者，随机分配给标准化管理（SM）或互动网络平台管理（INP）组。 SM集团经历了标准管理水肺过程。 INP集团经历了一种基于互动网络平台的新管理方法，称为“U呼吸”。在基线和两组的基准和1年后，评估了依从性率，症状和药物评分（CSMS），视觉模拟规模分数和鼻咽炎质量（RQLQ）结果评估了两组。结果：在治疗的第一年内，INP组的合规率比SM组更高，具有统计学意义差异（P <0.05）。 INP组表现出比SM组在VAS评分方面所做的更好的临床改进，以及除睡眠问题外的RQLQ得分（P <0.05）。结论：本研究证实，互动网络平台的应用对于改善患者的依从性和患者患者患者的治疗效果具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号